Nordic Pharma, Inc.
12 drugs in NADAC|12 Generic,0 Brand
Nordic Pharma, Inc. lists 12 NDCs in the CMS NADAC file (12 generic, 0 brand), at an average NADAC of $5.65 per unit, with a week-over-week move of -0.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
12
12G / 0B
Avg Price / Unit
$5.6475
$0.24 – $19.15
Avg 7d Change
-0.22%
Across 12 drugs with changes
7d Activity
of 12 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Desmopressin Acetate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Factor VIII Activator therapeutic class
Review the broader class where Nordic Pharma, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Nordic Pharma, Inc. make?
Nordic Pharma, Inc. lists 12 NDCs in the CMS NADAC file — 12 generic and 0 brand products.
What is the average price of Nordic Pharma, Inc. drugs?
The average NADAC across Nordic Pharma, Inc.'s portfolio is $5.6475 per unit, ranging from $0.2429 to $19.1479.
What types of drugs does Nordic Pharma, Inc. make?
Nordic Pharma, Inc. makes drugs across 9 FDA pharmacologic classes. The most common by NDC count are Factor VIII Activator (5), Vasopressin Analog (5), Anti-epileptic Agent (4), Mood Stabilizer (4), Aminoglycoside Antibacterial (1).
Has Nordic Pharma, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Nordic Pharma, Inc. in the openFDA feed.
How has Nordic Pharma, Inc.'s pricing changed recently?
Over the past 7 days, 6 Nordic Pharma, Inc. products rose and 6 fell, with a portfolio-wide average change of -0.2%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DESMOPRESSIN 40 MCG/10 ML VIAL Desmopressin Acetate | $19.1479 per ML | -6.33% |
DESMOPRESSIN 40 MCG/10 ML VIAL Desmopressin Acetate | $19.1479 per ML | -6.33% |
DESMOPRESSIN 40 MCG/10 ML VIAL Desmopressin Acetate | $19.1479 per ML | -6.33% |
NEOMYC-POLYM-DEXAMETH EYE DROP neomycin sulfate, polymyxin b sulfate and dexamethasone | $1.7823 per ML | +4.61% |
LAMOTRIGINE ODT 200 MG TABLET Lamotrigine | $1.6434 per EA | +12.12% |
LAMOTRIGINE ODT 100 MG TABLET Lamotrigine | $1.6250 per EA | -9.67% |
LAMOTRIGINE ODT 25 MG TABLET Lamotrigine | $1.2994 per EA | +2.57% |
LAMOTRIGINE ODT 50 MG TABLET Lamotrigine | $1.2710 per EA | -0.34% |
TIMOLOL MALEATE 0.5% EYE DROP Timolol Maleate | $1.2555 per EA | +5.76% |
TRANEXAMIC ACID 650 MG TABLET Tranexamic Acid | $0.8344 per EA | -2.61% |
DESMOPRESSIN ACETATE 0.2 MG TB Desmopressin Acetate | $0.3726 per EA | +0.68% |
DESMOPRESSIN ACETATE 0.1 MG TB Desmopressin Acetate | $0.2429 per EA | +3.23% |